PRPO · XBRL financial data

Precipio financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (PRPO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q3 FY23Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	4,518	4,329*	3,432	4,441	5,209	5,450*	4,929	5,654	6,767	6,699*	6,711	7,021
Revenue from contracts with customers	4,569	4,372*	3,478	4,507	5,280	5,311*	4,911	5,629	6,885	6,821*	6,961	7,021
Cost of goods and services sold	2,633	2,316*	2,512	2,725	2,932	2,804*	2,789	3,225	3,762	3,567*	3,986	3,885
Gross profit	1,885	2,013*	920	1,716	2,277	2,646*	2,140	2,429	3,005	3,132*	2,725	3,136
Research and development	—	year only	—	—	—	year only	—	—	—	year only	—	—
Total operating expenses	3,333	2,867*	2,994	2,925	2,874	2,982*	2,999	3,253	3,066	2,590*	4,153	3,735
Operating income (loss)	(1,448)	(854)*	(2,074)	(1,209)	(597)	(336)*	(859)	(824)	(61)	542*	(1,428)	(599)
Other income (expense)	—	—	—	(11)	(29)	(29)*	—	898	(18)	(16)*	—	380
Income tax expense (benefit)	—	year only	—	—	—	year only	—	—	—	year only	—	—
Net income (loss)	—	—	—	—	—	year only	(884)	74	—	year only	(1,443)	(219)
Earnings per share, basic USD per share	(1.04)	—	(1.46)	(0.83)	(0.42)	—	(0.59)	0.05	(0.05)	—	(0.81)	(0.12)
Earnings per share, diluted USD per share	(1.04)	—	(1.46)	(0.83)	(0.42)	—	(0.59)	0.05	(0.05)	—	(0.81)	(0.12)
Weighted average shares, basic thousands of shares	1,395	1,414*	1,426	1,464	1,480	1,492*	1,503	1,514	1,637	1,763*	1,783	1,787
Weighted average shares, diluted thousands of shares	1,395	1,414*	1,426	1,464	1,480	1,492*	1,503	1,602	1,637	1,675*	1,783	1,787

Balance sheet

CSV

Fiscal quarters (PRPO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q3 FY23Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	1,562	1,502	776	1,279	1,053	1,389	1,017	1,130	2,305	2,651	2,604	3,075
Accounts receivable	1,483	1,301	906	1,107	1,021	799	976	1,488	1,957	1,984	1,988	2,279
Inventory	636	384	532	653	590	724	825	1,059	788	935	870	776
Total current assets	4,309	3,682	2,595	3,364	3,255	3,451	3,278	4,053	5,668	6,039	5,932	6,537
Property and equipment, net	738	739	672	683	753	719	771	756	771	729	735	1,077
Right-of-use asset	668	612	556	498	447	395	1,573	1,756	2,431	2,565	2,451	2,334
Total assets	19,053	18,101	16,624	17,318	16,951	16,996	17,785	18,816	21,153	21,317	20,803	21,321
Accounts payable	2,513	622	905	855	701	618	906	1,164	1,138	1,131	1,363	972
Accrued liabilities	2,213	1,824	1,819	2,918	2,743	2,799	2,659	2,475	2,428	1,690	1,660	1,639
Current portion of long-term debt	334	235	133	249	444	297	147	29	30	30	30	73
Total current liabilities	5,454	3,141	3,327	4,595	4,478	4,271	4,331	4,353	4,453	3,752	3,810	3,701
Long-term debt	113	106	99	92	84	77	70	62	55	47	40	252
Lease liability, non-current	459	407	353	301	254	206	1,370	1,543	2,097	2,206	2,085	1,959
Total liabilities	6,051	3,672	3,850	5,203	5,006	4,902	6,087	6,528	7,404	6,756	6,636	6,563
Accumulated deficit	(99,075)	(98,150)	(100,229)	(101,449)	(102,075)	(102,440)	(103,324)	(103,250)	(103,329)	(102,803)	(104,246)	(104,465)
Total stockholders' equity	12,937	14,429	—	—	—	—	—	—	—	—	—	—
Total liabilities and equity	19,053	18,101	16,624	17,318	16,951	16,996	17,785	18,816	21,153	21,317	20,803	21,321
Common shares outstanding (cover page) thousands of shares	1,420	1,430	1,470	1,482	1,482	1,504	1,512	1,620	1,752	1,784	1,787	1,790

Cash flows

CSV

Fiscal quarters (PRPO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q3 FY23Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	—	—	—	—	—	year only	(884)	74	—	year only	(1,443)	(219)
Stock-based compensation	366*	390*	357	299*	398*	437*	423	449*	232*	105*	993	767*
Depreciation and amortization	310*	294*	304	297*	299*	299*	324	307*	307*	307*	281	291*
Net cash from operating activities	(896)*	114*	(667)	500*	41*	565*	(44)	353*	10*	366*	64	660*
Purchases of property and equipment	23*	49*	—	—	109*	44*	138	59*	54*	75*	50	132*
Net cash from investing activities	(23)*	(49)*	—	—	(109)*	(44)*	(138)	(59)*	(54)*	(75)*	(50)	(132)*
Proceeds from issuing common stock	0*	0*	67	11*	0*	0*	—	—	—	—	—	—
Proceeds from long-term debt	—	—	—	—	0*	0*	—	—	—	—	—	—
Net cash from financing activities	(92)*	(125)*	(59)	73*	(158)*	(185)*	(190)	(181)*	1,219*	55*	(61)	(57)*
Net change in cash	(1,011)*	(60)*	(726)	503*	(226)*	336*	(372)	113*	1,175*	346*	(47)	471*

Compare with peers

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Precipio	3,075	7,021	660*	1.8M	—	Q2 FY26 10-QJun 30, 2026
Focus Universal	1,600	675	(741)*	702,745	2.2 quarters	Q2 FY26 10-QJun 30, 2026
Harvard Bioscience	6,503	22,727	325*	4.6M	—	Q2 FY26 10-QJun 30, 2026
Bionano Genomics	3,730	8,171	(4,670)*	11.8M	2.1 quarters	Q2 FY26 10-QJun 30, 2026
MultiSensor AI Holdings	21,005	1,695	(2,392)*	2.2M	8.8 quarters	Q2 FY26 10-QJun 30, 2026
Optex Systems Holdings	6,175	9,729	2,323*	7.0M	—	Q3 FY26 10-QJun 28, 2026
Data I/O	10,843	5,149	(2,939)*	10.4M	3.7 quarters	Q2 FY26 10-QJun 30, 2026
ClearSign Technologies	9,889	not reported	(1,236)*	6.8M	8.0 quarters	Q2 FY26 10-QJun 30, 2026
Sypris Solutions	not reported	30,341	1,863*	23.0M	—	Q2 FY26 10-QJul 5, 2026

Not investment advice. Not affiliated with the U.S. SEC.